
The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.
Gordon Johnston is vice-president of regulatory sciences at the Generic Pharmaceutical Assocation.

The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.

Published: October 2nd 2009 | Updated: